Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InfuSystem Holdings (INFU) Cash from Operations (2016 - 2025)

Historic Cash from Operations for InfuSystem Holdings (INFU) over the last 17 years, with Q3 2025 value amounting to $8.5 million.

  • InfuSystem Holdings' Cash from Operations fell 1370.66% to $8.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.2 million, marking a year-over-year increase of 4670.66%. This contributed to the annual value of $20.5 million for FY2024, which is 8229.53% up from last year.
  • Latest data reveals that InfuSystem Holdings reported Cash from Operations of $8.5 million as of Q3 2025, which was down 1370.66% from $7.0 million recorded in Q2 2025.
  • In the past 5 years, InfuSystem Holdings' Cash from Operations ranged from a high of $9.8 million in Q3 2024 and a low of -$151000.0 during Q1 2023
  • Moreover, its 5-year median value for Cash from Operations was $4.3 million (2023), whereas its average is $4.5 million.
  • Per our database at Business Quant, InfuSystem Holdings' Cash from Operations surged by 37594.25% in 2021 and then tumbled by 10370.28% in 2023.
  • Quarter analysis of 5 years shows InfuSystem Holdings' Cash from Operations stood at $3.7 million in 2021, then grew by 23.04% to $4.6 million in 2022, then grew by 2.01% to $4.7 million in 2023, then soared by 70.27% to $7.9 million in 2024, then rose by 7.09% to $8.5 million in 2025.
  • Its Cash from Operations stands at $8.5 million for Q3 2025, versus $7.0 million for Q2 2025 and $1.8 million for Q1 2025.